Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 207

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Animal models of depression in drug discovery: A historical perspective

McArthur, Robert, Borsini, Franco · 2006 · Pharmacology Biochemistry and Behavior

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.pbb.2006.06.005

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Research works printed but not linked: 227

  1. Adam, 2000, Pharmacogenomics to predict drug response, Pharmacogenomics, 1, 5, 10.1517/14622416.1.1.5 · DOI
  2. Ader, 1982, Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus, Science, 215, 1534, 10.1126/science.7063864 · DOI · Paper page
  3. Adrien, 2002, Neurobiological bases for the relation between sleep and depression, Sleep Med Rev, 6, 341, 10.1016/S1087-0792(01)90200-X · DOI · Paper page
  4. Adrien, 1991, Sleep–wakefulness patterns in the helpless rat, Physiol Behav, 49, 257, 10.1016/0031-9384(91)90041-L · DOI
  5. Amer, 2004, Trends in early drug safety, Drug News Perspect, 17, 143
  6. Andrade, 2002, Continuation and maintenance ECT: a review of recent research, J ECT, 18, 149, 10.1097/00124509-200209000-00007 · DOI
  7. Anisman, 1979, Effects of inescapable shock on subsequent escape performance: catecholaminergic and cholinergic mediation of response initiation and maintenance, Psychopharmacology, 61, 107, 10.1007/BF00426724 · DOI · Paper page
  8. Askew, 1963, A simple screening procedure for imipramine-like antidepressant agents, Life Sci, 10, 725, 10.1016/0024-3205(63)90076-6 · doi:10.1016/0024-3205(63)90076-6
  9. Babington, 1973, The pharmacology of seizures induced by sensitization with low intensity brain stimulation, Pharmacol Biochem Behav, 1, 461, 10.1016/0091-3057(73)90013-0 · DOI
  10. Bai, 2001, Intra- and interstrain differences in models of “behavioural despair”, Pharmacol Biochem Behav, 70, 187, 10.1016/S0091-3057(01)00599-8 · DOI · Paper page
  11. Bale, 2003, Increased depression-like behaviours in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses, J Neurosci, 23, 5295, 10.1523/JNEUROSCI.23-12-05295.2003 · DOI · Paper page
  12. Baltzer, 1973, Antidepressant agents and reversal of diurnal activity cycles in the rats, Biol Psychiatry, 10, 199
  13. Banerjee, 1977, Development of beta-adrenergic receptor subsensitivity by antidepressants, Nature, 268, 455, 10.1038/268455a0 · DOI · Paper page
  14. Barr, 1998, Chronic mild stress has no effect on responding by rats for sucrose under a progressive ratio schedule, Physiol Behav, 64, 591, 10.1016/S0031-9384(98)00060-2 · DOI
  15. Barr, 2002, A ‘crash’ course on psychostimulant withdrawal as a model of depression, Trends Pharmacol Sci, 23, 475, 10.1016/S0165-6147(02)02086-2 · DOI
  16. Barron, 1965, Pharmacological properties of 3-dimethylamino-2-methyl-1-phenyl-1-o-tolylpropanol (SK and F 70463-A), J Pharm Pharmacol, 17, 509, 10.1111/j.2042-7158.1965.tb07713.x · doi:10.1111/j.2042-7158.1965.tb07713.x
  17. Benedetti, 2005, Neurobiological Mechanisms of the Placebo Effect, J Neurosci, 25, 10390, 10.1523/JNEUROSCI.3458-05.2005 · DOI · Paper page
  18. Berton, 1999, Behavioral, neuroendocrine and serotonergic consequences of single social defeat and repeated fluoxetine pretreatment in the Lewis rat strain, Neuroscience, 92, 327, 10.1016/S0306-4522(98)00742-8 · DOI
  19. Besson, 1999, Dopaminergic and opioidergic mediations of tricyclic antidepressants in the learned helplessness paradigm, Pharmacol Biochem Behav, 64, 541, 10.1016/S0091-3057(99)00102-1 · DOI
  20. Binks, 1979, A reward-reduction model of depression using self stimulating rats: an appraisal, Pharmacol Biochem Behav, 10, 441, 10.1016/0091-3057(79)90211-9 · DOI
  21. Blanchard, 2003, The Mouse Defence Test Battery: pharmacological and behavioural assays for anxiety and panic, Eur J Pharmacol, 463, 97, 10.1016/S0014-2999(03)01276-7 · DOI · Paper page
  22. Bohus, 1993, Immunological responses to social stress: dependence on social environment and coping abilities, Neuropsychobiology, 28, 95, 10.1159/000119008 · DOI
  23. Boivin, 2000, Influence of sleep–wake and circadian rhythm disturbances in psychiatric disorders, J Psychiatry Neurosci, 25, 446
  24. Borsini, 1995, Role of the serotonergic system in the forced swimming test, Neurosci Biobehav Rev, 19, 377, 10.1016/0149-7634(94)00050-B · DOI · Paper page
  25. Borsini, 1988, Is the forced swimming test a suitable model for revealing antidepressant activity?, Psychopharmacology, 94, 147, 10.1007/BF00176837 · DOI · Paper page
  26. Borsini, 1981, Immobility test: effects of 5-hydroxytryptaminergic drugs and role of catecholamines in the activity of some antidepressants, J Pharm Pharmacol, 33, 33, 10.1111/j.2042-7158.1981.tb13697.x · DOI
  27. Bourin, 1983, The value of the reserpine test in psychopharmacology, Arzneim-Forsh/Drug Res, 33, 1173
  28. Boutrel, 1999, Key role of 5-HT1B receptors in the regulation of paradoxical sleep as evidenced in 5-HT1B knock-out mice, J Neurosci, 19, 3204, 10.1523/JNEUROSCI.19-08-03204.1999 · DOI · Paper page
  29. Boutrel, 2002, Involvement of 5-HT1A receptors in homeostatic and stress-induced adaptive regulations of paradoxical sleep: studies in 5-HT1A knock-out mice, J Neurosci, 22, 4686, 10.1523/JNEUROSCI.22-11-04686.2002 · DOI · Paper page
  30. Broekkamp, 1980, Serotonin-mimetic and antidepressant drugs on passive avoidance learning by olfactory bulbectomized rats, Pharmacol Biochem Behav, 13, 643, 10.1016/0091-3057(80)90006-4 · DOI
  31. Brown, 1998, Mouse mutagenesis-systematic studies of mammalian gene function, Hum Mol Genet, 7, 1627, 10.1093/hmg/7.10.1627 · DOI
  32. Brown, 1988, Placebo response in depression: a search for predictors, Psychiatry Res, 26, 259, 10.1016/0165-1781(88)90119-9 · DOI
  33. Bunney, 2000, Molecular clock genes in man and lower animals: possible implications for circadian abnormalities in depression, Neuropsychopharmacology, 22, 335, 10.1016/S0893-133X(99)00145-1 · DOI · Paper page
  34. Buwalda, 1999, (Jul) Long-lasting deficient dexamethasone suppression of hypothalamic–pituitary–adrenocortical activation following peripheral CRF challenge in socially defeated rats, J Neuroendocrinol, 11, 513, 10.1046/j.1365-2826.1999.00350.x · DOI
  35. Buwalda, 2005, Long-term effects of social stress on brain and behavior: a focus on hippocampal functioning, Neurosci Biobehav Rev, 29, 83, 10.1016/j.neubiorev.2004.05.005 · DOI · Paper page
  36. Cairncross, 1978, A new model for the detection of antidepressants drugs: olfactory bulbectomy in the rats comparing to the existing models, J Pharmacol Methods, 1, 131, 10.1016/0160-5402(78)90018-9 · DOI
  37. Cairncross, 1979, Olfactory projection systems, drugs and behaviour: a review, Psychoneuroendocrinology, 4, 253, 10.1016/0306-4530(79)90009-X · DOI
  38. Clements-Jewery, 1978, The development of cortical beta-adrenoceptor subsensitivity in the rat by chronic treatment with trazodone, doxepin and mianserine, Neuropharmacology, 17, 779, 10.1016/0028-3908(78)90094-1 · DOI
  39. Colpaert, 1975, A critical study on RO-4-1284 antagonism in mice, Arch Int Pharmacodyn, 215, 40
  40. Cooper, 1980, Behavioural and biochemical effects of antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo, J Pharmacol Exp Ther, 215, 127
  41. Cornfeldt, 1982, Rat internal capsule lesion: a new test for detecting antidepressant, Fed Proc, 41, 1066
  42. Costa, 1960, Interactions between reserpine, chlorpromazine, and imipramine, Experentia, 16, 461, 10.1007/BF02171155 · DOI
  43. Cowan, 1974, Potentiation of picrotoxin-induced convulsions in mice by antidepressants. Specificity of the effect, Br J Pharmacol, 52, 432P
  44. Crawley, 1999, Behavioural phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioural tests, Brain Res, 835, 18, 10.1016/S0006-8993(98)01258-X · DOI · Paper page
  45. Crawley, 1997, Behavioural phenotypes of inbred mouse strains: implications and recommendations for molecular studies, Psychopharmacology, 132, 107, 10.1007/s002130050327 · DOI · Paper page
  46. Crowley, 2005, Opportunities to discover genes regulating depression and antidepressant response from rodent behavioural genetics, Curr Pharm Des, 11, 157, 10.2174/1381612053382278 · DOI
  47. Crowley, 2005, Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test, Psychopharmacology, 183, 257, 10.1007/s00213-005-0166-5 · DOI
  48. Cryan, 2005, Don't worry ‘B’ happy!: a role for GABA(B) receptors in anxiety and depression, Trends Pharmacol Sci, 26, 36, 10.1016/j.tips.2004.11.004 · DOI · Paper page
  49. Cryan, 2005, Assessing substrates underlying the behavioural effects of antidepressants using the modified rat forced swimming test, Neurosci Biobehav Rev, 29, 547, 10.1016/j.neubiorev.2005.03.008 · DOI · Paper page
  50. Cryan, 2005, The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice, Neurosci Biobehav Rev, 29, 571, 10.1016/j.neubiorev.2005.03.009 · DOI · Paper page
  51. Czeh, 2001, Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine, Proc Natl Acad Sci U S A, 98, 12796, 10.1073/pnas.211427898 · DOI · Paper page
  52. De Graaf, 1985, A set of behavioural tests predicting antidepressant activity, Drug Dev Res, 5, 291, 10.1002/ddr.430050402 · DOI
  53. deKloet, 2005, Stress, genes and the mechanism of programming the brain for later life, Neurosci Biobehav Rev, 29, 271, 10.1016/j.neubiorev.2004.10.008 · DOI · Paper page
  54. de Kloet, 2005, Stress and the brain: from adaptation to disease, Nat Rev Neurosci, 6, 463, 10.1038/nrn1683 · DOI · Paper page
  55. De Leon, 2001, Antiepileptic drugs for the acute and maintenance treatment of bipolar disorder, Harv Rev Psychiatry, 9, 209, 10.1080/10673220127901 · DOI
  56. Desan, 2000, Genetic polymorphism at the CLOCK gene locus and major depression, Am J Med Genet, 96, 418, 10.1002/1096-8628(20000612)96:3<418::AID-AJMG34>3.0.CO;2-S · DOI
  57. Detke, 1995, Active behaviours in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants, Psychopharmacology, 121, 66, 10.1007/BF02245592 · DOI · Paper page
  58. Detke, 1997, Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression, Exp Clin Psychopharmacol, 5, 107, 10.1037/1064-1297.5.2.107 · doi:10.1037/1064-1297.5.2.107 · Paper page
  59. Ducottet, 2003, Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice, Prog Neuropsychopharmacol Biol Psychiatry, 27, 625, 10.1016/S0278-5846(03)00051-4 · DOI · Paper page
  60. Dugovic, 2000, Sleep in the Wistar–Kyoto rat, a putative genetic animal model for depression, NeuroReport, 11, 627, 10.1097/00001756-200002280-00038 · DOI
  61. Duyk, 2003, Attrition and translation, Science, 302, 603, 10.1126/science.1090521 · DOI
  62. Einon, 1975, The development of intersession habituation and emergence in social reared and isolated rats, Dev Psychol, 8, 553, 10.1002/dev.420080613 · DOI
  63. Enna, 1983, Beta-adrenergic receptor regulation and antidepressants: the influence of adrenocorticotropin, J Neural Transm, 57, 297, 10.1007/BF01249000 · doi:10.1007/bf01249000
  64. Enserink, 1999, Can the placebo be the cure?, Science, 284, 238, 10.1126/science.284.5412.238 · DOI
  65. Faries, 2000, The responsiveness of the Hamilton Depression Rating Scale, J Psychiatr Res, 34, 3, 10.1016/S0022-3956(99)00037-0 · DOI · Paper page
  66. Ferris, 1983, Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain, Neuropharmacology, 22, 1257, 10.1016/0028-3908(83)90198-3 · DOI
  67. Fibiger, 1981, Increased intracranial self-stimulation in rats after long-term administration of desipramine, Science, 214, 683, 10.1126/science.7197394 · DOI
  68. Fink, 1960, Effects of psychopharmacologic agents on experimentally-induced seizures in mice, J Am Pharm Assoc, 49, 510, 10.1002/jps.3030490807 · doi:10.1002/jps.3030490807
  69. Francis, 1999, Maternal care, gene expression, and the development of individual differences in stress reactivity, Ann N Y Acad Sci, 896, 66, 10.1111/j.1749-6632.1999.tb08106.x · DOI · Paper page
  70. Frey, 1973, Sensitivity and responsivity measures for discrimination learning, Learn Motiv, 4, 327, 10.1016/0023-9690(73)90023-4 · DOI · Paper page
  71. Frisch, 1999, Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways, Mol Psychiatry, 4, 389, 10.1038/sj.mp.4000536 · DOI · Paper page
  72. Fuchs, 2005, Social stress in tree shrews as an animal model of depression: an example of a behavioural model of a CNS disorder, CNS Spectr, 10, 182, 10.1017/S1092852900010038 · DOI
  73. Fuchs, 1996, Psychosocial stress in tree shrews: clomipramine counteracts behavioral and endocrine changes, Pharmacol Biochem Behav, 54, 219, 10.1016/0091-3057(95)02166-3 · DOI · Paper page
  74. Gandolfi, 1984, The (−)-deprenyl actions on beta-adrenergic receptors require the integrity of brain serotonergic axon terminals, Eur J Pharmacol, 100, 233, 10.1016/0014-2999(84)90229-2 · doi:10.1016/0014-2999(84)90229-2
  75. Garattini, 1962, Effect of imipramine. Amitriptyline and their monomethyl derivatives on reserpine activity, J Pharm Pharmacol, 14, 509, 10.1111/j.2042-7158.1962.tb11130.x · doi:10.1111/j.2042-7158.1962.tb11130.x
  76. Garcha, 1985, Effects of some atypical antidepressants on beta-adrenoceptor binding and adenylate cyclase activity in the rat forebrain, Eur J Pharmacol, 108, 1, 10.1016/0014-2999(85)90276-6 · DOI
  77. Garzon, 1981, Hyperactivity induced in rats by long-term isolation: further studies on a new animal model for detection of antidepressants, Eur J Pharmacol, 74, 287, 10.1016/0014-2999(81)90047-9 · DOI
  78. Garzon, 1979, Antidepressants selectively antagonize the hyperactivity induced in rats by long-term isolation, Eur J Pharmacol, 59, 293, 10.1016/0014-2999(79)90293-0 · DOI
  79. Glatt, 2003, Pharmacogenetics of monoamine transporters, Pharmacogenomics, 4, 583, 10.1517/phgs.4.5.583.23789 · DOI
  80. Goodwin, 1982, Evidence that pathophysiology of depression and the mechanism of action of antidepressant drugs both involve alterations in circadian rhythms, vol. 32, 1
  81. Griebel, 2002, 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II: Characterization in rodent models of stress-related disorders, J Pharmacol Exp Ther, 301, 333, 10.1124/jpet.301.1.333 · DOI · Paper page
  82. Hagan, 1997, Revised CMS model, Psychopharmacology, 134, 354, 10.1007/s002130050466 · DOI
  83. Hall, 1984, Effect of destruction of central noradrenergic and serotonergic nerve terminals by systemic neurotoxins on the long-term effects of antidepressants on beta-adrenoceptors and 5-HT2 binding sites in the rat cerebral cortex, J Neural Transm, 59, 9, 10.1007/BF01249875 · doi:10.1007/bf01249875
  84. Hall, 1990, Acute and chronic desipramine treatment effects on rewarding electrical stimulation of the lateral hypothalamus, Pharmacol Biochem Behav, 37, 277, 10.1016/0091-3057(90)90334-E · DOI
  85. Halliwell, 1964, A comparison of imipramine, chlorpromazine and related drugs in various tests involving autonomic functions and antagonism of reserpine, Br J Pharmacol Chemother, 23, 330, 10.1111/j.1476-5381.1964.tb01590.x · DOI
  86. Hasler, 2004, Discovering endophenotypes for major depression, Neuropsychopharmacology, 29, 1765, 10.1038/sj.npp.1300506 · DOI · Paper page
  87. Healy D, (Ed.). The psychopharmacologists. I: Interviews by Dr David Healy. London: Altman, Chapman and Hall;1996.
  88. Hinde, 1966, Effects of 6-day maternal deprivation on rhesus monkey infants, Nature, 210, 1021, 10.1038/2101021a0 · DOI
  89. Horovitz, 1965, Selective block of rat mouse-killing by antidepressants, Life Sci, 4, 1909, 10.1016/0024-3205(65)90075-5 · doi:10.1016/0024-3205(65)90075-5
  90. Horovitz, 1966, Effects of drugs on the mouse-killing (muricide) test and its relationship to amygdaloid function, Int J Neuropharmacol, 5, 405, 10.1016/0028-3908(66)90005-0 · DOI
  91. Hrdina, 1979, Pharmacological modification of experimental depression in infant macaques, Psychopharmacology, 64, 89, 10.1007/BF00427351 · DOI
  92. Hughes, 1985, Measurement of reinforcement in depression: a pilot study, J Behav Ther Exp Psychiatry, 16, 231, 10.1016/0005-7916(85)90068-0 · DOI
  93. Hunter, 2000, Towards new models of disease and physiology in the neurosciences: the role of induced and naturally occurring mutations, Hum Mol Genet, 9, 893, 10.1093/hmg/9.6.893 · DOI
  94. Hurko, 2005, Translational Research in Central Nervous System Drug Discovery, NeuroRx, 2, 671, 10.1602/neurorx.2.4.671 · DOI
  95. Insel, 2006, Beyond efficacy: the STAR⁎D trial, Am J Psychiatry, 163, 5, 10.1176/appi.ajp.163.1.5 · DOI
  96. Jensen, 1962, Mother–infant relationship in the monkey, Macaca nemestrina: the effect of brief separation and mother–infant specificity, J Comp Physiol Psychol, 55, 131, 10.1037/h0048498 · DOI
  97. Justice, 1999, Mouse ENU mutagenesis, Hum Mol Genet, 8, 1955, 10.1093/hmg/8.10.1955 · DOI · Paper page
  98. Katz, 1981, Animal model of depression: effects of electroconvulsive shock therapy, Neurosci Biochem Rev, 5, 273, 10.1016/0149-7634(81)90009-9 · DOI
  99. Katz, 1982, A further parametric study of imipramine in an animal model of depression, Pharmacol Biochem Behav, 16, 969, 10.1016/0091-3057(82)90054-5 · DOI
  100. Katz, 1982, Animal model of depression: tests of three structurally and pharmacologically novel antidepressant compounds, Pharmacol Biochem Behav, 16, 973, 10.1016/0091-3057(82)90055-7 · DOI
  101. Kaufman, 1967, Depression in infant monkeys separated from their mothers, Science, 155, 1030, 10.1126/science.155.3765.1030 · DOI
  102. Keck, 2005, Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders, Neurosci Biobehav Rev, 29, 867, 10.1016/j.neubiorev.2005.03.003 · DOI
  103. Kelly, 1997, The olfactory bulbectomized rat as a model of depression: an update, Pharmacol Ther, 74, 299, 10.1016/S0163-7258(97)00004-1 · DOI · Paper page
  104. Ketter, 2003, Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders, J Clin Psychopharmacol, 23, 484, 10.1097/01.jcp.0000088915.02635.e8 · DOI
  105. Kinnier, 1980, Down regulation of dihydroalprenolol and imipramine binding sites in brain of rats repeatedly treated with imipramine, Eur J Pharmacol, 67, 289, 10.1016/0014-2999(80)90510-5 · doi:10.1016/0014-2999(80)90510-5
  106. Kirsch, 1998, Listening to Prozac but hearing placebo: a meta-analysis of antidepressant medication, Prev Treat, 1, 1
  107. Kirsch, 2005, The emperor's new drugs: an analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration, Prev Treat, 5, 1
  108. Kline, 1958, Clinical experience with iproniazid (marsilid), J Clin Exp Psychopathol, 19, 72
  109. Kokkinidis, 1980, Post-amphetamine depression of self-stimulation responding from the substantia nigra: reversal by tricyclic antidepressants, Pharmacol Biochem Behav, 13, 379, 10.1016/0091-3057(80)90242-7 · DOI
  110. Koolhaas, 1990, Single social defeat in male rats induces a gradual but long-lasting behavioural change: a model of depression?, Neurosci Res Commun, 7, 35
  111. Korte, 1995, Socially defeated male rats display a blunted adrenocortical response to a low dose of 8-OH-DPAT, Eur J Pharmacol, 272, 45, 10.1016/0014-2999(94)00621-D · DOI
  112. Kostowski, 1984, Activity of desipramine, fluoxetine and nomifensine on spontaneous and p-CPA-induced muricidal aggression, Pharmacol Res Commun, 16, 265, 10.1016/S0031-6989(84)80109-5 · DOI
  113. Kupferberg, 2001, Animal models used in the screening of antiepileptic drugs, Epilepsia, 42, 7, 10.1046/j.1528-1157.2001.0420s4007.x · doi:10.1046/j.1528-1157.2001.0420s4007.x
  114. Lander, 1988, Splitting schizophrenia, Nature, 336, 105, 10.1038/336105a0 · DOI
  115. Lapin, 1980, Adrenergic nonspecific potentiation of yohimbine toxicity in mice by antidepressants and related drugs and antiyohimbine action of antiadrenergic and serotonergic drugs, Psychopharmacology, 70, 179, 10.1007/BF00435311 · doi:10.1007/bf00435311
  116. Lehr, 1989, Distress call reactivation in isolated chicks: a behavioural indicator with high selectivity for antidepressants, Psychopharmacology, 97, 145, 10.1007/BF00442235 · DOI
  117. Leonard, 2000, Clinical implications of mechanisms of action of antidepressants, Adv Psychiatric Treat, 6, 178, 10.1192/apt.6.3.178 · DOI
  118. Leonard, 1981, Anatomical, physiological and behavioural aspects of olfactory bulbectomy in the rat, Int Rev Neurobiol, 22, 251, 10.1016/S0074-7742(08)60295-0 · DOI · Paper page
  119. Le Pen, 2002, Deficits in reward sensitivity in a neurodevelopmental rat model of schizophrenia, Psychopharmacology, 161, 434, 10.1007/s00213-002-1092-4 · DOI
  120. Lesch, 2004, Gene–environment interaction and the genetics of depression, J Psychiatry Neurosci, 29, 174
  121. Leshner, 1979, Effects of desmethylimipramine (DMI) on learned helplessness, Psychopharmacology, 66, 207, 10.1007/BF00427633 · DOI
  122. Licinio, 2001, The pharmacogenomics of depression, Pharmacogenomics J, 1, 175, 10.1038/sj.tpj.6500047 · DOI
  123. Lopez-Rubalcava, 2000, Strain differences in the behavioural effects of antidepressant drugs in the rat forced swimming test, Neuropsychopharmacology, 22, 191, 10.1016/S0893-133X(99)00100-1 · DOI · Paper page
  124. Maj, 1980, Studies on the action of antidepressant drugs of second generation, Pol J Pharmacol Pharm, 32, 437
  125. Maj, 1974, The effect of tricyclic antidepressants on apomorphine-induced hypothermia in the mouse, Pol J Pharmacol Pharm, 26, 329
  126. Malatynska, 1984, The effect of antidepressant drugs on dominance behaviour in rats competing for food, Pol J Pharmacol Pharm, 36, 531
  127. Malatynska, 2005, Submissive behaviour as a test for antidepressant drug activity, Pharmacol Biochem Behav, 83, 306, 10.1016/j.pbb.2005.08.020 · DOI
  128. Markou, 1992, Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations, Physiol Behav, 51, 111, 10.1016/0031-9384(92)90211-J · DOI · Paper page
  129. Martorana, 1979, The new antidepressant pirlindole, Arzneim-Forsh/Drug Res, 29, 946
  130. Matthews, 2005, Animal models of depression: navigating through the clinical fog, Neurosci Biobehav Rev, 29, 503, 10.1016/j.neubiorev.2005.03.005 · DOI
  131. Mayberg, 2002, The functional neuroanatomy of the placebo effect, Am J Psychiatry, 159, 728, 10.1176/appi.ajp.159.5.728 · DOI · Paper page
  132. McGrath, 1963, Potentation of the anti-reserpine effects of dihydroxyphenylalanine by antidepressants and stimulants, Nature, 199, 917, 10.1038/199917a0 · doi:10.1038/199917a0
  133. McGuffin, 1989, The genetics of depression and manic–depressive disorder, Br J Psychiatry, 155, 294, 10.1192/bjp.155.3.294 · DOI · Paper page
  134. McGuire, 1980, Differential effects of imipramine in rats as a function of DRL schedule value, Pharmacol Biochem Behav, 13, 691, 10.1016/0091-3057(80)90013-1 · DOI
  135. Miller, 1958, Central stimulation and other new approaches to motivation and reward, Am Psychol, 13, 100, 10.1037/h0042452 · DOI
  136. Mishra, 1980, Action of mianserin and zimelidine on the norepinephrine receptor coupled adenylate cyclase system in brain: subsensitivity without reduction in beta-adrenergic receptor binding, Neuropharmacology, 19, 983, 10.1016/0028-3908(80)90009-X · DOI · Paper page
  137. Mitchell, 2005, Antidepressant treatment and rodent aggressive behaviour, Eur J Pharmacol, 526, 147, 10.1016/j.ejphar.2005.09.029 · DOI
  138. Mitchell, 1992, Chronic treatment with clomipramine and mianserin increases the hierarchical position of subdominant rats housed in triads, Behav Pharmacol, 3, 239, 10.1097/00008877-199206000-00007 · doi:10.1097/00008877-199206000-00007
  139. Mitchell, 2003, Effects of single and repeated electroconvulsive shock on the social and agonistic behaviour of resident rats, Neuropharmacology, 44, 911, 10.1016/S0028-3908(03)00075-3 · DOI
  140. Mombereau, 2004, Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior, Neuropsychopharmacology, 29, 1050, 10.1038/sj.npp.1300413 · DOI · Paper page
  141. Moreau, 1997, Reliable monitoring of hedonic deficits in the chronic mild stress model of depression, Psychopharmacology, 134, 357, 10.1007/s002130050467 · DOI
  142. Moreau, 1992, Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behaviour in rats, Eur Neuropsychopharmacol, 2, 43, 10.1016/0924-977X(92)90035-7 · DOI · Paper page
  143. Moreau, 1995, Chronic mild stress-induced anhedonia model of depression; sleep abnormalities and curative effects of electroshock treatment, Behav Pharmacol, 6, 682, 10.1097/00008877-199511000-00003 · DOI
  144. Morpurgo, 1965, Influence of imipramine-like compounds and chlorpromazine on the reserpine–hypothermia in mice and the amphetamine–hyperthermia in rats, Med Pharmacol Exp Int J Exp Med, 2, 226
  145. Nagayama, 1980, Pre- and postsynaptic serotonergic manipulations in an animal model of depression, Pharmacol Biochem Behav, 15, 575, 10.1016/0091-3057(80)90283-X · DOI
  146. Nemeroff, 2005, The neurobiology of depression: inroads to treatment and new drug discovery, J Clin Psychiatry, 66, 5
  147. Nestler, 2002, Preclinical models: status of basic research in depression, Biol Psychiatry, 52, 503, 10.1016/S0006-3223(02)01405-1 · DOI · Paper page
  148. Nielsen, 2006, Corticotropin-releasing factor type-1 receptor antagonists: the next class of antidepressants?, Life Sci, 78, 909, 10.1016/j.lfs.2005.06.003 · DOI
  149. Nielsen, 2000, Intracranial self-stimulation and sucrose intake differ as hedonic measures following chronic mild stress: interstrain and interindividual differences, Behav Brain Res, 107, 21, 10.1016/S0166-4328(99)00110-2 · DOI
  150. Noreika, 1981, Delayed emergence of antidepressant efficacy following withdrawal in olfactory bulbectomized rats, Pharmacol Biochem Behav, 15, 393, 10.1016/0091-3057(81)90268-9 · doi:10.1016/0091-3057(81)90268-9
  151. O'Donnel, 1982, Effects of monoamine oxidase inhibitors on performance during differential reinforcement of low response rats, Psychopharmacology, 86, 55
  152. O'Donnell, 2005, Antidepressant effects assessed using behaviour maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule, Neurosci Biobehav Rev, 29, 785, 10.1016/j.neubiorev.2005.03.018 · DOI
  153. O'Neill, 2003, Animal models of depression: are there any, Hum Psychopharmacol Clin Exp, 18, 239, 10.1002/hup.496 · DOI
  154. Overmier, 1967, Effects of inescapable shock upon subsequent escape and avoidance responding, J Comp Physiol Psychol, 63, 28, 10.1037/h0024166 · DOI · Paper page
  155. Overstreet, 2004, Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression, Eur J Pharmacol, 497, 49, 10.1016/j.ejphar.2004.06.035 · DOI
  156. Overstreet, 2005, The Flinders Sensitive Line rat: a selectively bred putative animal model of depression, Neurosci Biobehav Rev, 29, 739, 10.1016/j.neubiorev.2005.03.015 · DOI · Paper page
  157. Owen, 1999, Norepinephrine transporter gene polymorphism is not associated with susceptibility to major depression, Psychiatry Res, 87, 1, 10.1016/S0165-1781(99)00050-5 · DOI
  158. Palmer, 2005, CNS drug discovery: challenges and solutions, Drug News Perspect, 18, 51
  159. Pandey, 1985, Beta adrenergic receptor function in depression and the effect of antidepressant drugs, Acta Pharmacol Toxicol, 56, 66
  160. Panksepp, 1978, Reduction of distress vocalization in chicks by opiate-like peptides, Brain Res Bull, 3, 663, 10.1016/0361-9230(78)90014-X · DOI
  161. Peroutka, 1980, Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding, Science, 210, 88, 10.1126/science.6251550 · DOI · Paper page
  162. Perrault, 1992, Activity of litoxetine and other serotonin uptake inhibitors in the tail suspension test in mice, Pharmacol Biochem Behav, 42, 45, 10.1016/0091-3057(92)90444-K · DOI
  163. Petty, 1980, Reversal of learned helplessness by imipramine, Commun Psychopharmacol, 3, 371
  164. Pizzagalli, 2005, Toward an objective characterization of an anhedonic phenotype: a signal-detection approach, Biol Psychiatry, 57, 319, 10.1016/j.biopsych.2004.11.026 · DOI · Paper page
  165. Porsolt, 1977, Behavioural despair in mice: a primary screening test for antidepressants, Arch Int Pharmacodyn, 229, 327
  166. Przegalinski, 1979, The effect of some new antidepressants on apomorphine-induced hypothermia in mice, J Pharm Pharmacol, 31, 560, 10.1111/j.2042-7158.1979.tb13586.x · doi:10.1111/j.2042-7158.1979.tb13586.x
  167. Puech, 1978, Imipramine antagonism of apomorphine-induced hypothermia: a non-dopaminergic interaction, Eur J Pharmacol, 47, 125, 10.1016/0014-2999(78)90383-7 · doi:10.1016/0014-2999(78)90383-7
  168. Puech, 1981, Antagonism of hypothermia and behavioural response to apomorphine: a simple, rapid and discriminating test for screening antidepressants and neuroleptics, Psychopharmacology, 75, 84, 10.1007/BF00433508 · DOI
  169. Quinton, 1963, The increase in the toxicity of yohimbine induced by imipramine and other drugs in mice, Br J Pharmacol Chemother, 21, 51, 10.1111/j.1476-5381.1963.tb01501.x · doi:10.1111/j.1476-5381.1963.tb01501.x
  170. Roszkowski, 1976, Augmentation of pentylenetetrazole induced seizures by tricyclic antidepressants, Mater Med Pol, 8, 141
  171. Roubertoux, 2001, Quantitative trait locus mapping: fishing strategy or replicable results?, Behav Genet, 31, 141, 10.1023/A:1010222328509 · DOI
  172. Rupniak, 2003, Animal models of depression: challenges from drug development, Behav Pharmacol, 14, 385
  173. Rusak, 2000, Chronobiology and mood disorders: background and introduction, J Psychiatry Neurosci, 25, 443
  174. Russell, 1982, Selective breeding for sensitivity to DFP: generalization of effects beyond criterion variables, Pharmacol Biochem Behav, 17, 885, 10.1016/0091-3057(82)90466-X · DOI
  175. Ryu, 2004, Association between norepinephrine transporter gene polymorphism and major depression, Neuropsychobiology, 49, 174, 10.1159/000077361 · DOI
  176. Sachs, 2003, Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD), Biol Psychiatry, 53, 1028, 10.1016/S0006-3223(03)00165-3 · DOI · Paper page
  177. Sahakian, 1975, The effects of psychomotor stimulants on stereotypy and locomotor activity in social deprived and control rats, Brain Res, 84, 195, 10.1016/0006-8993(75)90975-0 · DOI · Paper page
  178. Sahakian, 1977, The effects of isolation rearing on exploration in the rat, Anim Learn Behav, 5, 193, 10.3758/BF03214077 · DOI
  179. Sakurada, 1976, Sleep wakefulness rhythms in the olfactory bulb lesioned rat, Jpn J Pharmacol, 26, 606, 10.1016/S0021-5198(19)66020-8 · doi:10.1016/s0021-5198(19)66020-8
  180. Sarai, 1978, Desmethylimipramine-induced decrease in beta-adrenergic receptor binding in rat cerebral cortex, Biochem Pharmacol, 27, 2179, 10.1016/0006-2952(78)90293-9 · doi:10.1016/0006-2952(78)90293-9
  181. Schechter, 1979, Non-specificity of “behavioural despair” as an animal model of depression, Eur J Pharmacol, 60, 139, 10.1016/0014-2999(79)90212-7 · DOI
  182. Scherschlicht, 1982, Selective suppression of rapid eye movement sleep (REMS) in cats by typical and atypical antidepressants, Adv Biochem Psychopharmacol, 31, 359
  183. Schildkraut, 1965, The catecholamine hypothesis of affective disorders: a review of supporting evidence, Am J Psychiatry, 122, 509, 10.1176/ajp.122.5.509 · DOI · Paper page
  184. Schneider, 2001, National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE):Alzheimer disease trial methodology, Am J Geriatr Psychiatry, 9, 346, 10.1176/appi.ajgp.9.4.346 · DOI
  185. Schurhoff, 2003, Anhedonia in schizophrenia: a distinct familial subtype?, Schizophr Res, 61, 59, 10.1016/S0920-9964(02)00237-2 · DOI
  186. Seay, 1962, Mother–infant separation in monkeys, J Child Psychol Psychiatry, 3, 3, 10.1111/j.1469-7610.1962.tb02047.x · DOI · Paper page
  187. Seiden, 1985, Behavioural screen for antidepressants: the effect of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rat schedule, Psychopharmacology, 86, 55, 10.1007/BF00431684 · DOI
  188. Seligman, 1975, Learned helplessness in the rat: reversibility, time course and immunization, J Comp Physiol Psychol, 88, 542, 10.1037/h0076431 · DOI · Paper page
  189. Sellinger-Barnette, 1980, The effect of psychoactive drugs on beta-adrenergic receptor binding sites in rat brain, Neuropharmacology, 19, 447, 10.1016/0028-3908(80)90052-0 · DOI · Paper page
  190. Serretti, 2004, From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes, Psychopharmacology, 174, 490, 10.1007/s00213-004-1822-x · DOI
  191. Serretti, 2004, The pharmacogenomics of selective serotonin reuptake inhibitors, Pharmacogenomics J, 4, 233, 10.1038/sj.tpj.6500250 · DOI
  192. Sherman, 1979, A neuropharmacologically-relevant animal model of depression, Neuropharmacology, 18, 891, 10.1016/0028-3908(79)90087-X · DOI · Paper page
  193. Shepherd, 2006, Behaviour: smells, brains and hormones, Nature, 439, 149, 10.1038/439149a · doi:10.1038/439149a
  194. Sherman, 1982, Specificity of the learned helplessness model of depression, Pharmacol Biochem Behav, 16, 449, 10.1016/0091-3057(82)90451-8 · DOI · Paper page
  195. Shiromani, 1988, Increased REM sleep in rats selectively bred for cholinergic hyperactivity, Neuropsychopharmacology, 1, 27, 10.1016/0893-133X(88)90004-8 · DOI
  196. Silvestrini, 1982, Trazodone—A new type of antidepressant: a discussion of pharmacological data and their clinical implications, vol. 32, 327
  197. Simler, 1982, Gamma-aminobutyric acid in brain areas of isolated aggressive or non-aggressive inbred strains of mice, Pharmacol Biochem Behav, 16, 57, 10.1016/0091-3057(82)90013-2 · doi:10.1016/0091-3057(82)90013-2
  198. Slattery, 2005, GABAB receptor antagonist-mediated antidepressant-like behavior is serotonin-dependent, J Pharmacol Exp Ther, 312, 290, 10.1124/jpet.104.073536 · DOI
  199. Sofia, 1969, Effects of centrally active drugs on four models of experimentally-induced aggression in rodents, Life Sci, 8, 705, 10.1016/0024-3205(69)90259-8 · doi:10.1016/0024-3205(69)90259-8
  200. Sofia, 1969, Structural relationship and potency of agents which selectively block mouse killing (muricide) behaviour in rats, Life Sci, 8, 1201, 10.1016/0024-3205(69)90049-6 · doi:10.1016/0024-3205(69)90049-6

200 of 227 shown

Cited by

See all 207

Metadata

Authors
McArthur, R., & Borsini, F.
Venue
Pharmacology Biochemistry and Behavior
Publisher
Elsevier BV
Published
2006-07
Volume
84
Issue
3
Pages
436-452
ISSN
0091-3057 (ISSN-L)
OpenAlex
W2111265419
Cited by
207
References
36
FWCI
9.62
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Animal models of depression in drug discovery: A historical perspective. https://app.cochat.ai/papers/10.1016/j.pbb.2006.06.005
The paper
McArthur, R., & Borsini, F. (2006). Animal models of depression in drug discovery: A historical perspective. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2006.06.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.